Literature DB >> 11865441

Host resistance in the brain against Toxoplasma gondii.

Yasuhiro Suzuki1.   

Abstract

Interferon (IFN)-gamma-dependent, cell-mediated immunity plays the major role in resistance against development of toxoplasmic encephalitis (TE). Humoral immunity also participates in controlling Toxoplasma gondii in the brain. Resistance is operative under collaboration among T and B cells, IFN-gamma-producing non-T cells, microglia, astrocytes, and dendritic cells. A number of cytokines, including IFN-gamma, mediate interactions between these cells and activation of effector cells that prevent intracellular replication of the parasite. The L(d) gene confers resistance against development of TE in mice. In humans, the HLA-DQ1 and -DQ3 genes are involved in regulating the resistance and susceptibility. Since these genes are a part of the major histocompatibility complex, which regulates the immune responses, the regulation of the responses by these genes appears to be important for determining host resistance to this disease. Strains of T. gondii also affect development of TE. Genotypes of the parasite may be an important factor for determining development of TE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11865441     DOI: 10.1086/337999

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection.

Authors:  Rajarshi Bhadra; Jason P Gigley; Imtiaz A Khan
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

2.  The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey.

Authors:  Brad D Pearce; Deanna Kruszon-Moran; Jeffrey L Jones
Journal:  Biol Psychiatry       Date:  2012-02-10       Impact factor: 13.382

3.  A survey of Toxoplasma gondii antibodies by latex agglutination assay in dairy goats in Northern Tanzania.

Authors:  Emmanuel Senyael Swai; Jackson Eliona Kaaya
Journal:  Trop Anim Health Prod       Date:  2012-05-30       Impact factor: 1.559

Review 4.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia.

Authors:  Claudia Rozenfeld; Rodrigo Martinez; Sérgio Seabra; Celso Sant'anna; J Gabriel R Gonçalves; Marcelo Bozza; Vivaldo Moura-Neto; Wanderley De Souza
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

6.  Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis.

Authors:  E Fuller Torrey; John J Bartko; Zhao-Rong Lun; Robert H Yolken
Journal:  Schizophr Bull       Date:  2006-11-03       Impact factor: 9.306

7.  Relationship between Toxoplasma gondii seropositivity and acoustic startle response in an inner-city population.

Authors:  Nick M Massa; Erica Duncan; Tanja Jovanovic; Kimberly Kerley; Lei Weng; Lauren Gensler; Samuel S Lee; Seth Norrholm; Abigail Powers; Lynn M Almli; Charles F Gillespie; Kerry Ressler; Bradley D Pearce
Journal:  Brain Behav Immun       Date:  2016-11-21       Impact factor: 7.217

Review 8.  Advances in imaging the innate and adaptive immune response to Toxoplasma gondii.

Authors:  Beena John; Wolfgang Weninger; Christopher A Hunter
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

9.  Cytokine and antibody responses of reactivated murine toxoplasmosis upon administration of dexamathasone.

Authors:  Ki-Nam Kang; In-Uk Choi; Dae-Whan Shin; Young-Ha Lee
Journal:  Korean J Parasitol       Date:  2006-09       Impact factor: 1.341

10.  CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis.

Authors:  Fangli Lu; Shiguang Huang; Lloyd H Kasper
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.